A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma-Reference-Cited by-同舟云学术

A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma

Published:2013-08 Issue:2 Volume:144 Page:411-419
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Garcia Gilles,Magnan Antoine,Chiron Raphaël,Contin-Bordes Cécile,Berger Patrick,Taillé Camille,Devouassoux Gilles,de Blay Frédéric,Couderc Louis-Jean,Didier Alain,O'Callaghan Dermot S.,Girodet Pierre-Olivier,Bourdeix Isabelle,Le Gros Vincent,Humbert Marc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference28 articles.

1. A working classification of asthma;Rackemann;Am J Med,1947

2. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences;Humbert;Immunol Today,1999

3. Phenotypes of asthma revisited upon the presence of atopy;Nieves;Respir Med,2005

4. Allergic vs nonallergic asthma: what makes the difference?;Romanet-Manent;Allergy,2002

5. Global strategy for asthma management and prevention: GINA executive summary;Bateman;Eur Respir J,2008

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new biologic drugs: Which children with asthma should get what?;Pediatric Pulmonology;2024-09-13

2. Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials;European Respiratory Review;2024-04-24

3. Results of omalizumab treatment in chronic eosinophilic pneumonia: Real-life data;Tuberk Toraks;2024-03-26

4. The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma;European Respiratory Journal;2024-03-07

5. Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma;Respirology;2024-01-31